TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Go NAP SACC: A Pilot Study Evaluating the Nutrition Tool of the Web-based Tool Based on the NAP SACC Program
Brief Summary: The purpose of this project is to evaluate the effectiveness of Go NAP SACC (Get online with Nutrition and Physical Activity Self-Assessment for Child Care), a suite of web-based tools designed to help child care programs improve their nutrition environment (specifically classrooms serving 3-5 year olds) over the course of 4 months.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Go NAP SACC | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Go NAP SACC; Assigned to Arm(s): Intervention group
B: Arm Label: Cucumber; Type: EXPERIMENTAL; Interventions: Other: Cucumber snack | Arm Label: Pepper; Type: EXPERIMENTAL; Interventions: Other: Pepper snack | Arm Label: Tomato; Type: EXPERIMENTAL; Interventions: Other: Tomato snack | Arm Label: Vegetable variety; Type: EXPERIMENTAL; Interventions: Other: Vegetable variety snack | Arm Label: Apple; Type: EXPERIMENTAL; Interventions: Other: Apple snack | Arm Label: Peach; Type: EXPERIMENTAL; Interventions: Other: Peach snack | Arm Label: Pineapple; Type: EXPERIMENTAL; Interventions: Other: Pineapple snack | Arm Label: Fruit variety; Type: EXPERIMENTAL; Interventions: Other: Fruit variety snack | Intervention Type: OTHER; Name: Cucumber snack; Assigned to Arm(s): Cucumber | Intervention Type: OTHER; Name: Pepper snack; Assigned to Arm(s): Pepper | Intervention Type: OTHER; Name: Tomato snack; Assigned to Arm(s): Tomato | Intervention Type: OTHER; Name: Vegetable variety snack; Assigned to Arm(s): Vegetable variety | Intervention Type: OTHER; Name: Apple snack; Assigned to Arm(s): Apple | Intervention Type: OTHER; Name: Peach snack; Assigned to Arm(s): Peach | Intervention Type: OTHER; Name: Pineapple snack; Assigned to Arm(s): Pineapple | Intervention Type: OTHER; Name: Fruit variety snack; Assigned to Arm(s): Fruit variety
C: Arm Label: Vegetable exposure; Type: EXPERIMENTAL; Interventions: Other: Vegetable exposure | Arm Label: VIPP-Feeding Infants; Type: EXPERIMENTAL; Interventions: Behavioral: VIPP-Feeding Infants | Arm Label: Exposure + VIPP-FI; Type: EXPERIMENTAL; Interventions: Other: Vegetable exposure, Behavioral: VIPP-Feeding Infants | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Vegetable exposure; Assigned to Arm(s): Exposure + VIPP-FI, Vegetable exposure | Intervention Type: BEHAVIORAL; Name: VIPP-Feeding Infants; Assigned to Arm(s): Exposure + VIPP-FI, VIPP-Feeding Infants | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
D: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Lifestyle counseling; Assigned to Arm(s): Lifestyle counseling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Go NAP SACC: A Pilot Study Evaluating the Nutrition Tool of the Web-based Tool Based on the NAP SACC Program
Brief Summary: The purpose of this project is to evaluate the effectiveness of Go NAP SACC (Get online with Nutrition and Physical Activity Self-Assessment for Child Care), a suite of web-based tools designed to help child care programs improve their nutrition environment (specifically classrooms serving 3-5 year olds) over the course of 4 months.


Options:
A: Arm Label: Program SI! educational intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Program SI! educational intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Program SI! educational intervention; Assigned to Arm(s): Program SI! educational intervention
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Go NAP SACC | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Go NAP SACC; Assigned to Arm(s): Intervention group
C: Arm Label: Experimental: Phase 1 Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 1 Mealtime support activities; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Arm Label: Experimental: Phase 2- Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 2- Meal Delivery and Receipt of Cookware; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Intervention Type: BEHAVIORAL; Name: Mealtime Supports; Assigned to Arm(s): Experimental: Phase 1 Mealtime support activities, Experimental: Phase 2- Meal Delivery and Receipt of Cookware | Intervention Type: BEHAVIORAL; Name: Usual Exposure; Assigned to Arm(s): Experimental: Phase 1 Usual Exposure, Experimental: Phase 2- Usual Exposure
D: Arm Label: A: experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (B): experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (c): experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (D): control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Obesity-Children | Intervention Type: BEHAVIORAL; Name: Obesity-Children; Assigned to Arm(s): (B): experimental, (D): control group, (c): experimental, A: experimental

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Go NAP SACC: A Pilot Study Evaluating the Nutrition Tool of the Web-based Tool Based on the NAP SACC Program
Brief Summary: The purpose of this project is to evaluate the effectiveness of Go NAP SACC (Get online with Nutrition and Physical Activity Self-Assessment for Child Care), a suite of web-based tools designed to help child care programs improve their nutrition environment (specifically classrooms serving 3-5 year olds) over the course of 4 months.


Options:
A: Arm Label: Nutrition and Physical Activity Training; Type: EXPERIMENTAL; Interventions: Behavioral: NAP-SACC Child Care Wellness Program | Arm Label: Delayed Intervention Group; Type: OTHER; Interventions: Behavioral: NAP-SACC Child Care Wellness Program | Intervention Type: BEHAVIORAL; Name: NAP-SACC Child Care Wellness Program; Assigned to Arm(s): Delayed Intervention Group, Nutrition and Physical Activity Training
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Go NAP SACC | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Go NAP SACC; Assigned to Arm(s): Intervention group
C: Arm Label: Physical Activity Preschool Intervention; Type: EXPERIMENTAL; Interventions: Other: Physical Activity Preschool Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physical Activity Preschool Intervention; Assigned to Arm(s): Physical Activity Preschool Intervention
D: Arm Label: Train-the-Trainers Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Caregivers- Healthy Children Toolkit | Arm Label: Attention Control Arm; Type: OTHER; Interventions: Behavioral: Safety Curriculum | Intervention Type: BEHAVIORAL; Name: Healthy Caregivers- Healthy Children Toolkit; Assigned to Arm(s): Train-the-Trainers Arm | Intervention Type: BEHAVIORAL; Name: Safety Curriculum; Assigned to Arm(s): Attention Control Arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Culturally-tailored Narrative Intervention to Target Disparities in Obesity
Brief Summary: The purpose of this study is to determine the efficacy of a community-based behavioral intervention (H2GO!) on decreasing sugar-sweetened beverage consumption and promoting water consumption among school-aged youth and parents/caregivers. We hypothesize that participants in the intervention site will demonstrate reduced sugar-sweetened beverage intake intake and increased water intake compared to participants in the comparison site at 2 and 6 months follow-up.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Rewards; Type: EXPERIMENTAL; Interventions: Behavioral: F&V Bonus | Arm Label: Restrictions; Type: EXPERIMENTAL; Interventions: Behavioral: Restriction | Arm Label: Rewards plus restrictions; Type: EXPERIMENTAL; Interventions: Behavioral: Bonus & Restriction | Intervention Type: BEHAVIORAL; Name: F&V Bonus; Assigned to Arm(s): Rewards | Intervention Type: BEHAVIORAL; Name: Restriction; Assigned to Arm(s): Restrictions | Intervention Type: BEHAVIORAL; Name: Bonus & Restriction; Assigned to Arm(s): Rewards plus restrictions
B: Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to Arm(s): N/A
C: Arm Label: Feedback only; Type: EXPERIMENTAL; Interventions: Behavioral: Feedback letters | Arm Label: Feedback plus incentives; Type: EXPERIMENTAL; Interventions: Behavioral: Feedback plus incentives | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Feedback letters; Assigned to Arm(s): Feedback only | Intervention Type: BEHAVIORAL; Name: Feedback plus incentives; Assigned to Arm(s): Feedback plus incentives
D: Arm Label: H2GO! intervention; Type: EXPERIMENTAL; Interventions: Behavioral: H2GO! | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: H2GO!; Assigned to Arm(s): H2GO! intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Brief Summary: The purpose of this study was to evaluate the safety, infectivity, and immunogenicity of a single intranasal dose of a recombinant live-attenuated respiratory syncytial virus (RSV) vaccine in RSV-seronegative infants 6 to 24 months of age.

This study was a companion study to CIR 312.


Options:
A: Arm Label: RSV group; Type: EXPERIMENTAL; Interventions: Biological: RSV vaccine GSK3003891A | Arm Label: Boostrix group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Boostrix | Intervention Type: BIOLOGICAL; Name: RSV vaccine GSK3003891A; Assigned to Arm(s): RSV group | Intervention Type: BIOLOGICAL; Name: Boostrix; Assigned to Arm(s): Boostrix group
B: Arm Label: Placebo + Inactivated Influenza Vaccine (IIV); Type: ACTIVE_COMPARATOR; Interventions: Biological: IIV, Other: Placebo | Arm Label: MEDI7510 + IIV; Type: EXPERIMENTAL; Interventions: Biological: MEDI7510, Biological: IIV | Intervention Type: BIOLOGICAL; Name: MEDI7510; Assigned to Arm(s): MEDI7510 + IIV | Intervention Type: BIOLOGICAL; Name: IIV; Assigned to Arm(s): MEDI7510 + IIV, Placebo + Inactivated Influenza Vaccine (IIV) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo + Inactivated Influenza Vaccine (IIV)
C: Arm Label: RSV LID cp ΔM2-2 Vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV LID cp ΔM2-2 Vaccine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: RSV LID cp ΔM2-2 Vaccine; Assigned to Arm(s): RSV LID cp ΔM2-2 Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: RSV LID ΔM2-2 Vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV LID ΔM2-2 Vaccine | Arm Label: Placebo Vaccine; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo Vaccine | Intervention Type: BIOLOGICAL; Name: RSV LID ΔM2-2 Vaccine; Assigned to Arm(s): RSV LID ΔM2-2 Vaccine | Intervention Type: BIOLOGICAL; Name: Placebo Vaccine; Assigned to Arm(s): Placebo Vaccine

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer
Brief Summary: The purpose of this research study is to address the challenge of symptom management for hospitalized patients with cancer.


Options:
A: Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: quality of life pathway | Arm Label: control group; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo control | Intervention Type: BEHAVIORAL; Name: quality of life pathway; Assigned to Arm(s): intervention group | Intervention Type: OTHER; Name: placebo control; Assigned to Arm(s): control group
B: Arm Label: PCI Group; Type: OTHER; Interventions: Other: Patient Concerns Inventory | Arm Label: Non PCI Group; Type: OTHER; Interventions: Other: No Patient Concerns Inventory | Intervention Type: OTHER; Name: Patient Concerns Inventory; Assigned to Arm(s): PCI Group | Intervention Type: OTHER; Name: No Patient Concerns Inventory; Assigned to Arm(s): Non PCI Group
C: Arm Label: Routine data collection; Type: ACTIVE_COMPARATOR; Interventions: Other: Routine Data collection | Arm Label: Feedback of patient-reported outcomes; Type: EXPERIMENTAL; Interventions: Other: Routine Data collection, Other: Feedback of patient-reported outcomes | Intervention Type: OTHER; Name: Routine Data collection; Assigned to Arm(s): Feedback of patient-reported outcomes, Routine data collection | Intervention Type: OTHER; Name: Feedback of patient-reported outcomes; Assigned to Arm(s): Feedback of patient-reported outcomes
D: Arm Label: IMPROVED Intervention; Type: EXPERIMENTAL; Interventions: Other: IMPROVED | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: IMPROVED; Assigned to Arm(s): IMPROVED Intervention | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE-CONVERSION)
Brief Summary: A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in participants with dialysis-dependent chronic kidney disease (DD-CKD)


Options:
A: Arm Label: Vadadustat; Type: EXPERIMENTAL; Interventions: Drug: Vadadustat | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Vadadustat; Assigned to Arm(s): Vadadustat | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa
B: Arm Label: Molidustat (BAY85-3934); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY85-3934) | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Molidustat (BAY85-3934); Assigned to Arm(s): Molidustat (BAY85-3934) | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa
C: Arm Label: 0.5mg GSK1278863; Type: EXPERIMENTAL; Interventions: Drug: GSK1278863 | Arm Label: 2mg GSK1278863; Type: EXPERIMENTAL; Interventions: Drug: GSK1278863 | Arm Label: 5mg GSK1278863; Type: EXPERIMENTAL; Interventions: Drug: GSK1278863 | Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Other: Placebo | Intervention Type: DRUG; Name: GSK1278863; Assigned to Arm(s): 0.5mg GSK1278863, 2mg GSK1278863, 5mg GSK1278863 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Molidustat group; Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY85-3934), Drug: Placebo of Darbepoetin alfa | Arm Label: Darbepoetin alfa group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa, Drug: Placebo of Molidustat (BAY85-3934) | Intervention Type: DRUG; Name: Molidustat (BAY85-3934); Assigned to Arm(s): Molidustat group | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa group | Intervention Type: DRUG; Name: Placebo of Molidustat (BAY85-3934); Assigned to Arm(s): Darbepoetin alfa group | Intervention Type: DRUG; Name: Placebo of Darbepoetin alfa; Assigned to Arm(s): Molidustat group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Double Blind Comparison of Atosiban in Patients With Repeated Implantation Failure Undergoing IVF Treatment
Brief Summary: This study intends to carry out a prospective, randomized, double blind and controlled study to compare the influence of Atosiban and placebo on uterine contraction frequency, endometrial blood flow perfusion, oxytocin and serum concentration of PGF2α, embryo implantation rate and clinical pregnancy rate on the RIF population after fresh embryo transfer, so as to further clarify the curative effect of Atosiban in the treatment of RIF and provide evidence-based basis for Atosiban for application in RIF population.


Options:
A: Arm Label: atosiban; Type: EXPERIMENTAL; Interventions: Drug: atosiban | Arm Label: 0.9% salain; Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.9% saline | Intervention Type: DRUG; Name: atosiban; Assigned to Arm(s): atosiban | Intervention Type: DRUG; Name: 0.9% saline; Assigned to Arm(s): 0.9% salain
B: Arm Label: Endometrial biopsy arm; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial biopsy, Device: Transvaginal ultrasound | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Endometrial biopsy; Assigned to Arm(s): Endometrial biopsy arm | Intervention Type: DEVICE; Name: Transvaginal ultrasound; Assigned to Arm(s): Endometrial biopsy arm
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: PIPELLE ENDOMETRIAL SAMPLING | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: PIPELLE ENDOMETRIAL SAMPLING; Assigned to Arm(s): 1
D: Arm Label: Nolasiban 900 mg; Type: EXPERIMENTAL; Interventions: Drug: Nolasiban | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Nolasiban; Assigned to Arm(s): Nolasiban 900 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Double Blind Comparison of Atosiban in Patients With Repeated Implantation Failure Undergoing IVF Treatment
Brief Summary: This study intends to carry out a prospective, randomized, double blind and controlled study to compare the influence of Atosiban and placebo on uterine contraction frequency, endometrial blood flow perfusion, oxytocin and serum concentration of PGF2α, embryo implantation rate and clinical pregnancy rate on the RIF population after fresh embryo transfer, so as to further clarify the curative effect of Atosiban in the treatment of RIF and provide evidence-based basis for Atosiban for application in RIF population.


Options:
A: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Drug: Metformin | Arm Label: Control group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo administration | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Experimental group | Intervention Type: DRUG; Name: Placebo administration; Assigned to Arm(s): Control group
B: Arm Label: M: Metformin P: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Metformin / Placebo treatment for 4 months | Intervention Type: DRUG; Name: Metformin / Placebo treatment for 4 months; Assigned to Arm(s): M: Metformin P: Placebo
C: Arm Label: atosiban; Type: EXPERIMENTAL; Interventions: Drug: atosiban | Arm Label: 0.9% salain; Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.9% saline | Intervention Type: DRUG; Name: atosiban; Assigned to Arm(s): atosiban | Intervention Type: DRUG; Name: 0.9% saline; Assigned to Arm(s): 0.9% salain
D: Arm Label: Atosiban used before embryo transfer; Type: EXPERIMENTAL; Interventions: Drug: Atosiban | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban used before embryo transfer

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients (MOTIVATE-HF): Study Protocol of a Three-arm Multicenter Randomized Controlled Trial
Brief Summary: The aims of this study will be to evaluate the effect of motivational interviewing (MI) to improve self-care in heart failure (HF) patients and caregiver contributions to HF self-care. Also this study will evaluate the effect of MI on the following secondary outcomes: In HF patients: HF somatic symptom perception, generic and specific quality of life, anxiety and depression, sleep quality, mutuality with caregiver, hospitalizations, use of emergency services, and mortality; In caregivers: generic quality of life, anxiety and depression, mutuality with patient, preparedness, social support and sleep quality.


Options:
A: Arm Label: Motivational interviewing only for patients; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interviewing | Arm Label: Motivational interviewing to patients and caregivers; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interviewing | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational interviewing; Assigned to Arm(s): Motivational interviewing only for patients, Motivational interviewing to patients and caregivers
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic Pill Bottle, Incentives, Social Influence | Intervention Type: BEHAVIORAL; Name: Electronic Pill Bottle, Incentives, Social Influence; Assigned to Arm(s): Intervention
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Virtual Communities of practice | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Virtual Communities of practice; Assigned to Arm(s): Intervention group
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Healing Circles; Type: EXPERIMENTAL; Interventions: Behavioral: Healing Circles | Intervention Type: BEHAVIORAL; Name: Healing Circles; Assigned to Arm(s): Healing Circles

Answer: A